Literature DB >> 6346302

The lymphomas--current management.

T A Lister, J S Malpas.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6346302      PMCID： PMC2417488          DOI： 10.1136/pgmj.59.690.219

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  22 in total

1.  The radical radiotherapy of regionally localized Hodgkin's disease.

Authors:  H S KAPLAN
Journal:  Radiology       Date:  1962-04       Impact factor: 11.105

2.  A study of Hodgkin's disease treated by irradiation.

Authors:  M V PETERS; K C MIDDLEMISS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1958-01

3.  Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases.

Authors:  E B HICKS; H RAPPAPORT; W J WINTER
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

4.  Cell receptor studies on seven cases of diffuse histiocytic malignant lymphoma (reticulum cell sarcoma).

Authors:  J A Habeshaw; A E Stuart
Journal:  J Clin Pathol       Date:  1975-04       Impact factor: 3.411

Review 5.  Lymphomas in children.

Authors:  J S Malpas
Journal:  Semin Hematol       Date:  1982-10       Impact factor: 3.851

6.  Evidence for an orderly progression in the spread of Hodgkin's disease.

Authors:  S A Rosenberg; H S Kaplan
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

7.  Septicemia and meningitis in children splenectomized for hodgkin's disease.

Authors:  R R Chilcote; R L Baehner; D Hammond
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

8.  Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.

Authors:  E M McKelvey; J A Gottlieb; H E Wilson; A Haut; R W Talley; R Stephens; M Lane; J F Gamble; S E Jones; P N Grozea; J Gutterman; C Coltman; T E Moon
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

9.  Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.

Authors:  G Bonadonna; A Santoro; V Bonfante; P Valagussa
Journal:  Cancer Treat Rep       Date:  1982-04

10.  Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.

Authors:  P J Dady; T J McElwain; D E Austin; A Barrett; M J Peckham
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640
View more
  1 in total

1.  Rare cancers and specialist centres.

Authors:  R T Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.